Tecovirimat

Overview

Tecovirimat is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1257073).

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Tecovirimat expires 7 Aug 2032. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

N-[(1R,2R,6S,7S,8S,10R)-3,5-dioxo-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide

Canonical SMILES

C1[C@@H]2[C@H]1[C@@H]3C=C[C@H]2[C@@H]4[C@H]3C(=O)N(C4=O)NC(=O)C5=CC=C(C=C5)C(F)(F)F

InChIKey

CSKDFZIMJXRJGH-VWLPUNTISA-N